Search Results
Results found for "Helen Su"
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
At CA1-subicular presynaptic terminals 5-HT1B and GABAB receptors colocalize.
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
Subsequent experiments using primary astrocyte cultures revealed that Gi -DREADD stimulation significantly of the astrocytic Gi pathway attenuated intracellular calcium transients triggered by LPS treatment, suggesting
- Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors
Crystal structures suggest ligand access to the orthosteric binding site of MT1 and MT2 receptors through The side-chain flexibility of Tyr5.38 was significantly different in the two receptor subtypes, as assessed Our simulations also suggest that the open state of Tyr5.38 generates a small pocket on the surface of
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the range of
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Many cause receptor misfolding and failure to reach the cell surface. that engage nascent mutant GPCRs in the endoplasmic reticulum, stabilizing folding and "rescuing" cell surface We previously demonstrated rescue of cell surface expression of luteinizing hormone receptor mutants Cell surface expression was severely reduced to ≤18% of wild-type (WT) for 11, modestly reduced to 66% of certain mutant FSHRs with severely reduced cell surface expression.
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
intracellular context ("in-cell") or those focused on characterizing molecules or events at the cell surface some key NMR techniques applied for on-cell NMR studies through both solution- and solid-state NMR and survey focus on the application of on-cell NMR spectroscopy to characterize ligand interactions with cell surface We also provide a brief survey of the applicability of on-cell NMR approaches to other classes of cell surface molecules.
- Co-activation of GPCRs facilitate GIRK-dependent current
present study examined the interaction between D2 and GABAB receptors using transient applications of sub-saturating heterologous facilitation was modelled based on the known cooperative interaction between the G protein βγ subunits The results suggest that the cooperative interaction between G βγ subunits and GIRK channels determines
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
The TAS1R2 and TAS1R3 subunits are members of a small family of class C GPCRs whose members share the TAS1R2 contains the primary binding site for most of the sweet-tasting compounds, including natural sugars ligand affinities of hTAS1R2-VFT were drastically reduced through the introduction of single amino acid substitutions
- Immunomodulatory Role of Neuropeptides in the Cornea
This review focuses on the role of neuropeptides in maintaining the homeostasis of the ocular surface
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
August 2022 Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for Substance agreement with Indivior PLC (LON: INDV) for discovering and developing novel oral gamma-aminobutyric acid subtype
- GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures
And they avoid the costly surprises that appear when in vitro conclusions collide with human physiology These nonlinearities matter: Competitive inhibition decreases as substrate increases. Uncompetitive inhibition strengthens as substrate increases—opposite of intuition. A compound may appear benign with one substrate and problematic with another. Kenakin reveals the substrate strategy needed for credible DDI assessment.
- How Collaboration Drives GPCR Discoveries
It’s survival. Suddenly, the anomalies aligned.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
The resulting multiparametric datasets are well-suited for GPCR research, where receptor trafficking, For GPCR assay developers, HCS supports: Quantitative visualization of receptor internalization and Assay Design and Pilot Optimization Successful HCS begins with a clearly defined biological question Probe panels—such as lysosomal dyes or cytoskeletal markers—can be integrated to support multiplexed At Celtarys, we remain committed to enabling this transition and supporting researchers as they design
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Scientific progress doesn’t guarantee startup success; strategic clarity does. By the time it surfaces, you’ve lost two months of budget and alignment. 2️⃣ Milestone redefinition Most biotech founders don’t suffer from having the wrong people. They suffer because everyone has a different idea of what their role actually is. And suddenly, it becomes obvious what to kill and what to scale. ✅ That’s the power of strategic realignment
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Watch Episode #177 The Experiment That Was Never Meant to Succeed When David Hodson’s lab teamed up with visualization tool Impact: Shared widely → now used globally to map GPCR activity in live systems The success peripheral contributions to metabolic therapy Guide how next-generation incretin drugs are designed Support
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Surgery electives meant long nights, constant patient responsibilities, and unpredictable call schedules For Hodson, one sustained curiosity thread involved a protein released by alpha cells in the pancreas Suddenly, the puzzle snapped into place. A long-running side project became a central insight.
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Others show subtle curvature or slope deviations. It ’s a screening tool, not a substitute for rigorous Schild validation. Common revelations include: Mixtures of receptor subtypes producing hybrid response patterns.
- How Schild Analysis Protects Your Conclusions in GPCR Research
Catch subtle mechanistic drift. GPCR is a nonprofit organization , and Premium Membership directly supports our mission to make reliable University content, and an integrated view of publications, events, insights, and opportunities designed to support
- How GPCR Collaboration Built an Innovation Engine
programs This design had a strategic effect : talent density increased, but so did interdisciplinary surface Suddenly, we could do experiments that individual labs just couldn’t afford. But luck alone doesn’t sustain an ecosystem.
- From Pipettes to Platforms: The Evolution of GPCR Research
Suddenly, questions that were too risky or expensive to ask in the “manual era” became accessible. Today, success depends less on manual precision and more on experimental design, data interpretation,
- How GPCR Spatial Signaling Sparked a Scientific Journey
It was supposed to be just a summer project—routine pipetting, repetitive assays, a box to tick before Yet that summer research placement cracked open a new reality: the thrill of asking questions no one She moved from “What am I supposed to do?” to “What happens if I try this?” It might be quiet, subtle—an idea you can’t stop thinking about. Pay attention to that. For young scientists, that summer moment is waiting.
- Molecular creativity in drug discovery
Upcoming events: Global GPCR summits and pharmacology forums shaping 2026 priorities. spatial GPCR signaling shifts discovery—and how leadership, mentorship, and vision shape translational success GPCR evolved from a grassroots effort to a global force in GPCR science—one rooted in connection, sustainability
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Opium, for example, was used for dysentery and relief of suffering as early as the 3rd century BC; its Diuretic action discovered in sulfanilamide derivatives led to furosemide; sedative effects of early What matters now is not the category , but the fit: Does the chemical matter support the therapeutic Subscribers gain weekly lectures led by Dr. next decade trying to understand. 40 years of expertise at your fingertips: Explore the full library ➤ Subscribe
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
This year, we focused on building for sustainability — strengthening operations, expanding partnerships GPCR stronger, more connected, and more capable of supporting our growing community. We’re continuing to seek new strategic partners who share our goal of supporting the GPCR community GPCR is evolving — thoughtfully, inclusively, and sustainably.
- GPCR Collaboration: From Models to Medicine
Suddenly, computational shortcuts weren’t enough. In his view, collaboration is not a bonus or an optional supplement—it is the only way GPCR drug discovery Supporting them is a medicinal chemist who can design and synthesize new scaffolds when commercial libraries If docking can suggest binding modes but can’t resolve nanomolar potency differences, they say so. Biased signaling, allosteric binding sites, and subtype selectivity mean there is rarely a straight line
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
such as differentiating agonists from antagonists, predicting biased agonism, or achieving receptor subtype For Carlsson, a prediction is only valid if it survives wet-lab testing. If a method can’t resolve subtle potency differences, the team prefers to acknowledge that limitation But success depends on researchers who can manage expectations, build trust, and integrate across disciplines
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
A well-behaved molecule in a dish can fail spectacularly in vivo, leaving teams with years of sunk costs How CRO Communication Impacts GPCR Drug Development Success Even the best science falters without operational For scientists in discovery, this means two things: Technical clarity drives survival. Subscribe to The Kenakin Brief today ➤
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August AbbVie Completes Acquisition of Cerevel Therapeutics Nxera Pharma attended the Drug Discovery Ecosystem Summit
- From Failed Experiments to Predictive GPCR Models
When he first began working in a lab, success seemed elusive: experiments often failed, and bench work A summer spent purifying proteins highlighted his discomfort at the bench. His introduction came through a practical suggestion: explore a new protein family that was gaining traction This success was a revelation—it was possible not only to interpret experimental data but to forecast He believes genuine interest—not trends or external validation—is what sustains long-term scientific
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
framework to predict duration, penetration, and PK/PD separation—so decisions move faster and risks surface Breakthroughs this week: nanomedicines targeting PAR2 for sustained analgesia; Emerging Voices in GPCR Upcoming events: Membrane-mimetic screening; GPCR Forum 2025; GPCR-TDD Summit Europe. If your team is designing covalent or tight-binding candidates, these principles reduce surprises and 🗞️ Weekly research, careers & event intelligence 🤝 Members-only networking, AMAs & matchmaking 💡 Support



















